Efforts by the Tertiary Education Trust Fund (TETFund) to make possible impact in the Nigerian health sector is seen yielding results as its COVID-19 vaccine- funded project would be ready for first clinical trial in November.
This is contained in a statement by the acting director, public affair
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
